Nova Eye Medical (EYE.AX) Earnings Analysis
Nova Eye Medical (EYE.AX) next reports earnings on 2026-08-26. It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -5.27.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EYE.AX next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.02B |
EYE.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-27 | -0.01382 AUD | n/a | n/a | n/a |
| 2025-02-21 | -0.0235 AUD | -0.00673 AUD | -249.2% | Miss |
| 2024-10-31 | -0.01454 AUD | n/a | n/a | n/a |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
EYE.AX valuation and analyst view
| Trailing P/E | -5.27 |
|---|---|
| Trailing EPS | -0.02468 AUD |
| Price / book | 2.43 |
| Dividend yield | 0.00% |
| Market cap | 0.04B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Nova Eye Medical (EYE.AX)'s next earnings date?
Nova Eye Medical is next scheduled to report on 2026-08-26 and revenue estimate of 0.02B.
Did EYE.AX beat earnings last quarter?
Consensus estimate data was not available for EYE.AX's 2025-08-27 report.
What is EYE.AX's earnings track record?
Over the last 1 reported quarters with consensus data, EYE.AX beat estimates 0 times (0%).
What is EYE.AX's current P/E ratio and EPS?
EYE.AX trades at a trailing P/E of -5.27 on trailing EPS of -0.024681102946881563 AUD.
What do analysts rate EYE.AX?
EYE.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.